05-20-2005: Dendritic NanoTechnologies Inc. (DNT) announced a patent-pending development: a new family of scalable, precision dendrimer nanostructures. The new technology, developed by DNT, is called Priostar(TM) and offers a significant advantage over other precision nanostructures by reducing the complexity and duration of the synthesis process. The new Priostar family of scalable, precision dendrimers breaks through previous cost barriers and addresses industry needs for nanostructures that can be manufactured in high volumes at costs attractive for a wide variety of uses.
Priostar dendrimers ("Prio" comes from the Greek for fast, while "star" represents the shape of the dendrimer) are unique in that they can be produced in large quantities to precise tolerances. For example, they can be engineered to meet the FDA's rigid requirements for precision, scalability, and reproducibility needed for biomedical products, and yet can be produced in the larger quantities required for use in advanced materials, coatings, personal and household applications, and other commercial markets. The Priostar family of dendrimers promises to offer unique competitive advantages to DNT's commercial business partners.
Watchlist
This is where you can add this news to your personal favourites
Dendritic NanoTechnologies Inc. (DNT) announced a patent-pending development: a new family of scalable, precision dendrimer nanostructures. The new technology, developed by DNT, is called Priostar(TM) and offers a significant advantage over other precision nanostructures by reducing the com ... more
Dendritic NanoTechnologies Inc. (DNT), The Dow Chemical Company and Starpharma have reached an agreement that provides DNT and Starpharma with ownership or access to the world's broadest patent portfolio in the field of dendrimers, and establishes the companies as leading providers of marke ... more